Intrexon | XON - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agenus USD 128M 21M 2026-03
Alaunos Therapeutics USD 7M 2M 2026-03
Amgen USD 195.44B 5.55B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 22.65B 3.92B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
MacroGenics USD 184M 82M 2026-03
MannKind USD 1.32B 559M 2026-06
Merck USD 317.37B 20.27B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Veracyte USD 4.69B 2.12B 2026-06
Xencor USD 1.19B 301M 2026-06